Abstract| Volume 23, ISSUE 10, SUPPLEMENT , S45, October 2017

Serum Levels of Exocrine Pancreatic Enzyme in Patients with Acute Decompensated Heart Failure

      Background: Acute decompensated heart failure (ADHF) can damage systemic organs through the poor perfusion and/or congestion. The interaction between ADHF and exocrine pancreatic function was rarely investigated. Methods: We compared admission levels of serum amylase or lipase (as suggestive of exocrine pancreatic function) between patients admitted for ADHF (N = 102) and those admitted for non-ADHF causes (N = 35). Correlates to amylase or lipase were assessed by multiple regression analysis. In HF patients, associations between low amylase or lipase levels and clinical outcomes (composite of all-cause mortality and/or ADHF rehospitalization) were analyzed in the multivariate Cox regression models. Results: ADHF patients had significantly lower serum levels of amylase (median, 54 IU/L versus 68 IU/L, P = .001) and lipase (25 IU/L versus 31 IU/L, P = .018) compared with non-HF group. Amylase correlated directly with blood urea nitrogen (BUN) (coefficient, 0.552; P < .001), albumin (coefficient, 0.233; P = .020), and inversely with BNP levels (coefficient, −0.227, P = .024). Lipase correlated directly with BUN (coefficient, 0.377; P < .001) and inversely with BNP levels (coefficient, −0.364; P < .001). Although there was no association between low amylase levels and clinical outcomes, low lipase levels (<18 IU/L) was significantly associated with worse clinical outcome (hazard ratio, 1.81; P = .025). Conclusion: ADHF patients may be suffering from exocrine pancreatic insufficiency, which can be associated with poor long-term clinical outcomes possibly through malnutrition.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of Cardiac Failure
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect